What does Groupe santé CHC do?

Groupe santé CHC is registered with the CBE as active in: Ziekenhuizen. Non-profit, started on 8 December 1976, 23 establishments.

What is the address of Groupe santé CHC?

The registered office of Groupe santé CHC is located at Boulevard de Patience et Beaujonc 9, 4000 Liège.

Is Groupe santé CHC still active?

Yes. According to the CBE (30 September 2026) Groupe santé CHC is active, legal situation “Normale toestand”, started on 8 December 1976.

Is Groupe santé CHC registered on Peppol?

Yes, Groupe santé CHC is registered on the Peppol network with ID 0208:0416805238.

What is the enterprise number of Groupe santé CHC?

The enterprise number of Groupe santé CHC is BE0416805238.

When was Groupe santé CHC founded?

Groupe santé CHC was founded on 8 December 1976.

Who are the directors of Groupe santé CHC?

According to the 2025 annual accounts, the directors of Groupe santé CHC are: LA MUTUALITE CHRETIENNE DE LIEGE , André KILESSE, Constant JEHAES, Pierre BARATTO, Thierry WIMMER, VALERIA SARETTO , Claire BOVEROUX, Jean-Marie BERTRAND.

Is Groupe santé CHC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 December 1976; 5 annual accounts filed, latest fiscal year 2025; 13 directors known from the annual account; 23 establishments in the CBE.

How much profit did Groupe santé CHC make in 2025?

Groupe santé CHC posted a profit after taxes of € 12,257,147 in financial year 2025.

What is the revenue of Groupe santé CHC?

In its most recent annual accounts (2025), Groupe santé CHC reported revenue of € 691,562,114.

How much does an employee at Groupe santé CHC earn?

The average wage cost per full-time employee at Groupe santé CHC was € 76,800 in 2025: staff costs of € 306.7 million for 3,991.1 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Groupe santé CHC have?

According to the 2025 annual accounts, Groupe santé CHC has 3,991.1 full-time equivalents (FTE).

Groupe santé CHC (Non-profit) - Liège - BE0416805238

Dossier Groupe santé CHC, printed on 30 September 2026 from databakkes.be/en/0416805238/groupe-sante-chc. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Groupe santé CHC from Liège, company number BE0416805238, closed financial year 2025 with a result of € 12.3 million after tax. For that financial year Groupe santé CHC recorded revenue of € 691.6 million and equity of € 171.3 million. Compared with financial year 2024, the result moved from € 13.2 million to € 12.3 million. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 171.3 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 12.3 million

▼ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 19.5 million

▲ 66% vs 2024

Cash and bank balances on the last day of the fiscal year.

People and assets in 2025

Full-time equivalents

3,991.1

▲ 22.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 222.6 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 306.7 million

▲ 4% vs 2024

€ 76,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 28.3 million

▼ 13% vs 2024

Of which on lease € 2.4 million.

Debts at end 2025

Bank debt ≈ 11 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 344 million

▼ 4% vs 2024

€ 30.3 million is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.

Owed to suppliers

€ 131.9 million

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 122 days on average.

Taxes and wages

€ 49.6 million

▲ 4% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Revenue	€ 565,123,328 Revenue 2022: € 565,123,328 First fiscal year in the series	€ 623,834,065 Revenue 2023: € 623,834,065 ▲ 10% vs 2022 (€ 565,123,328) Favourable step	€ 672,278,079 Revenue 2024: € 672,278,079 ▲ 8% vs 2023 (€ 623,834,065) Favourable step	€ 691,562,114 Revenue 2025: € 691,562,114 ▲ 3% vs 2024 (€ 672,278,079) Favourable step	▲ 3%
Profit after taxes	€ 7,715,821 Profit after taxes 2022: € 7,715,821 First fiscal year in the series	€ 5,950,949 Profit after taxes 2023: € 5,950,949 ▼ 23% vs 2022 (€ 7,715,821) Unfavourable step	€ 13,208,994 Profit after taxes 2024: € 13,208,994 ▲ 122% vs 2023 (€ 5,950,949) Favourable step	€ 12,257,147 Profit after taxes 2025: € 12,257,147 ▼ 7% vs 2024 (€ 13,208,994) Unfavourable step	▼ 7%
Equity	€ 134,145,729 Equity 2022: € 134,145,729 First fiscal year in the series	€ 140,068,298 Equity 2023: € 140,068,298 ▲ 4% vs 2022 (€ 134,145,729) Favourable step	€ 154,145,792 Equity 2024: € 154,145,792 ▲ 10% vs 2023 (€ 140,068,298) Favourable step	€ 171,342,998 Equity 2025: € 171,342,998 ▲ 11% vs 2024 (€ 154,145,792) Favourable step	▲ 11%
Total debts	€ 546,142,870 Total debts 2022: € 546,142,870 First fiscal year in the series	€ 564,090,955 Total debts 2023: € 564,090,955 ▲ 3% vs 2022 (€ 546,142,870) Unfavourable step	€ 548,147,768 Total debts 2024: € 548,147,768 ▼ 3% vs 2023 (€ 564,090,955) Favourable step	€ 539,120,583 Total debts 2025: € 539,120,583 ▼ 2% vs 2024 (€ 548,147,768) Favourable step	▼ 2%
Cash	€ 6,657,153 Cash 2022: € 6,657,153 First fiscal year in the series	€ 19,476,331 Cash 2023: € 19,476,331 ▲ 193% vs 2022 (€ 6,657,153) Favourable step	€ 11,759,408 Cash 2024: € 11,759,408 ▼ 40% vs 2023 (€ 19,476,331) Unfavourable step	€ 19,505,840 Cash 2025: € 19,505,840 ▲ 66% vs 2024 (€ 11,759,408) Favourable step	▲ 66%
Land & buildings	€ 142,685,203 Land & buildings 2022: € 142,685,203 First fiscal year in the series	€ 142,427,909 Land & buildings 2023: € 142,427,909 Unchanged (€ 142,685,203) Unchanged	€ 154,287,975 Land & buildings 2024: € 154,287,975 ▲ 8% vs 2023 (€ 142,427,909) Unchanged	€ 149,152,784 Land & buildings 2025: € 149,152,784 ▼ 3% vs 2024 (€ 154,287,975) Unchanged	▼ 3%
Retained profit	€ 97,760,759 Retained profit 2022: € 97,760,759 First fiscal year in the series	€ 103,711,707 Retained profit 2023: € 103,711,707 ▲ 6% vs 2022 (€ 97,760,759) Favourable step	€ 115,190,450 Retained profit 2024: € 115,190,450 ▲ 11% vs 2023 (€ 103,711,707) Favourable step	€ 127,447,597 Retained profit 2025: € 127,447,597 ▲ 11% vs 2024 (€ 115,190,450) Favourable step	▲ 11%
Bank debt	€ 371,601,189 Bank debt 2022: € 371,601,189 First fiscal year in the series	€ 377,576,117 Bank debt 2023: € 377,576,117 ▲ 2% vs 2022 (€ 371,601,189) Unfavourable step	€ 358,634,353 Bank debt 2024: € 358,634,353 ▼ 5% vs 2023 (€ 377,576,117) Favourable step	€ 344,038,264 Bank debt 2025: € 344,038,264 ▼ 4% vs 2024 (€ 358,634,353) Favourable step	▼ 4%
Balance sheet total	€ 723,043,788 Balance sheet total 2022: € 723,043,788 First fiscal year in the series	€ 747,174,963 Balance sheet total 2023: € 747,174,963 ▲ 3% vs 2022 (€ 723,043,788) Unchanged	€ 751,498,254 Balance sheet total 2024: € 751,498,254 ▲ 1% vs 2023 (€ 747,174,963) Unchanged	€ 762,880,568 Balance sheet total 2025: € 762,880,568 ▲ 2% vs 2024 (€ 751,498,254) Unchanged	▲ 2%
Employees (FTE)	3,762.2 Employees (FTE) 2022: 3,762.2 First fiscal year in the series	3,873.7 Employees (FTE) 2023: 3,873.7 ▲ 111.5 vs 2022 (3,762.2) Unchanged	3,968.9 Employees (FTE) 2024: 3,968.9 ▲ 95.2 vs 2023 (3,873.7) Unchanged	3,991.1 Employees (FTE) 2025: 3,991.1 ▲ 22.2 vs 2024 (3,968.9) Unchanged	▲ 22.2

Key figures of Groupe santé CHC, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Groupe santé CHC?

What happened at Groupe santé CHC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Thierry WIMMER stepped down as director. NBB
2029 VALERIA SARETTO stepped down as director. NBB
2029 Claire BOVEROUX stepped down as director. NBB
2029 Jean-Marie BERTRAND stepped down as director. NBB
2029 FERNAND GRIFNEE stepped down as director. NBB
2029 MICHEL DE LAMOTTE stepped down as director. NBB
2029 Jean-Michel DOGNE stepped down as director. NBB
2027 Constant JEHAES stepped down as director. NBB

In short

From € 7.7 million profit in 2022 to € 12.3 million profit in 2025.

Best year ever: 2024, with € 13.2 million profit.

Pays suppliers within 122 days on average.

Original PDFs at the National Bank ↗

A new publication or filing at Groupe santé CHC? We notify you, reason included.

Follow Groupe santé CHC

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Groupe santé CHC

Centre de Senologie Docteurs Crevecoeur 100%

CENTRE EUROPEEN DE REEDUCATION 100%

CHC New Dev 99.2%

LEGIAPARKBIS 49%

It owns 100% of Centre de Senologie Docteurs Crevecoeur, 100% of CENTRE EUROPEEN DE REEDUCATION, 99.2% of CHC New Dev and 49% of LEGIAPARKBIS itself.

See the full network in the app

Directors

According to the 2025 annual accounts

LA MUTUALITE CHRETIENNE DE LIEGE

Director · represented by Christian SMETZ, Valérie NOTELAERS

Also active at: CENTRE LOCAL DE PROMOTION DE LA SANTE DE HUY-WAREMME, CHC New Dev, Le 37, Centre de planning et de consultation familiale et conjugale

since 2023 · until 2027

André KILESSE

Director

since 2023 · until 2027

Constant JEHAES

Director

Also active at: C.C.A.F.C., CHC New Dev

since 2023 · until 2027

Pierre BARATTO

Director

Also active at: S.A TRANSPORTS GIET - BODARWE, INTERTRAFF, CHC New Dev, BOD & BARA CONSULT

since 2023 · until 2027

Thierry WIMMER

Director

Also active at: VEDIA, FLHM PUBLICUM

since 2025 · until 2029

VALERIA SARETTO

Director

Also active at: CAUTION MUTUELLE DES METIERS ET NEGOCES, CHC New Dev

since 2025 · until 2029

Claire BOVEROUX

Director

Also active at: CHC New Dev

since 2025 · until 2029

Jean-Marie BERTRAND

Vice-chairman of the board

since 2025 · until 2029

XAVIER DRION

Chairman of the board

Also active at: CENTRE DE SENOLOGIE DOCTEURS CREVECOEUR, CENTRE EUROPEEN DE REEDUCATION, CHC New Dev, Fondation Fauconnier MJ, MOVE, LEGIAPARKBIS, Fondation CHC

since 2023 · until 2027

FERNAND GRIFNEE

Director

Also active at: Federatie van de elektriciteits- en gasnetbeheerders in België, CHC New Dev, ATRIAS

since 2025 · until 2029

MICHEL DE LAMOTTE

Director

since 2025 · until 2029

Jean-Michel DOGNE

Director

Also active at: CHC New Dev, LEGIAPARKBIS

since 2025 · until 2029

Elisabetta CALLEGARI

Director

Also active at: CHC New Dev, MOVE

since 2021 · until 2025

Establishments

Establishment units

Physical locations of this company

Registered office

Boulevard de Patience et Beaujonc 9

4000 Liège

2.138.408.352

Boulevard de Patience et Beaujonc 2

4000 Liège